Cancer Biomarker Market Size to Reach $39.7 Billion by 2028

The cancer biomarker market has witnessed substantial growth in recent years, and according to market analysis, it is poised to reach $22.77 billion in 2024 from $19.74 billion in 2023, reflecting a compound annual growth rate (CAGR) of 15.4%.

Topics: Pharmaceuticals Industry Insights

Global Oncology Precision Medicine Market to Reach $364 Billion by 2035

Precision medicine, often known as personalized medicine, holds significant potential in the treatment of oncological disorders. Precision medicine refers to the development of tailored therapies by utilizing genomic information, environmental factors, and the patient's lifestyle.

Topics: Pharmaceuticals Industry Insights

Continuous Manufacturing Market to Hit $4.3 Billion by 2035

Technological innovation is at the forefront of continuous manufacturing, enabling real-time analysis and helping to eliminate the chances of errors resulting in failure.

Topics: Pharmaceuticals Industry Insights

Top 4 Things to Know About the Global Sleep Apnea Devices Market

The sleep apnea device market has undergone rapid transformation, driven by growing awareness about the consequences associated with disruptive or poor sleep conditions. Sleep apnea is a severe sleeping disorder in which a person experiences interruptive breathing or loud snoring.

Topics: Pharmaceuticals Medical Devices Industry Insights

Lipid Nanoparticle Manufacturing Market Dynamics: Expert Insights

Lipid nanoparticles are novel drug delivery systems that enhance treatment outcomes in various ways, including targeting specificity, improving therapeutic efficacy, increasing water solubility, and reducing toxicity.

Topics: Pharmaceuticals Industry Insights

Clinical Trial Software: Innovations Shaping the Future of Clinical Trials

A clinical trial is an important component of the drug development and approval process. The data obtained from clinical trials is crucial to meet regulatory compliance, helping to ensure a drug’s efficacy and safety for human use.

Topics: Software & Enterprise Computing Pharmaceuticals Industry Insights

U.S. Weight Loss Industry Grows to $90 Billion, Fueled by Obesity Drugs Demand

The total U.S. weight loss market is estimated to have grown to a historic peak of $90 billion in 2023, boosted by soaring sales of the popular prescription GLP-1 weight loss drugs. This is a major paradigm shift toward medical programs, and a major challenge for competing commercial diet companies, which lost $1+ billion in revenues since 2022.

Topics: Food & Beverage Pharmaceuticals Industry Insights

Supply Chain Disruptions Limits Growth in the Sleep Diagnostics Market

Obstructive sleep apnea (OSA) affects roughly one out of every five people in the United States and it is estimated that 85% of people suffering from OSA are underdiagnosed (Santilli, et al., 2021).

Topics: Diagnostics Pharmaceuticals Medical Devices Industry Insights

U.S. Medical Spas Industry Boosted by Pandemic, with Strong Growth Outlook to 2027

The U.S. medical spas industry has more than tripled in size (in terms of revenue) since 2012, and was worth $17.5 billion in 2022. The COVID-19 pandemic actually boosted this business, as consumers in Zoom meetings viewed their facial faults and decided to correct them.

Topics: Travel & Leisure Pharmaceuticals Industry Insights

Global Breast Reconstruction Market Growth: Analysis and Forecasts

The survival rate of breast cancer has improved significantly over the last decade, shifting the focus of treatment towards quality of life, as opposed to simply survival. Breast cancer treatment typically consists of surgery, radiation therapy and/or medicines. A common procedure many breast cancer patients undergo is a mastectomy.

Topics: Pharmaceuticals Healthcare Industry Insights